Previous in vivo and in vitro studies from our laboratory have reveale
d a line of pharmacological evidence supporting histamine H-3 receptor
(s) involvement in the control of gastric acid secretion. We have rece
ntly extended our studies to the human gastric tumoral cell HGT-1. Thi
s cell was found to contain an H-3 receptor inhibiting basal and carba
chol-stimulated inositol phosphate formation. Furthermore, we were abl
e to solubilize and affinity-purify this receptor in the form of a sin
gle 70 kDa protein. These findings are the first biochemical descripti
on of the H-3 receptor subtype and the first direct demonstration that
this subtype can occur on a non-neural cell. Furthermore, they provid
e a molecular basis to explain its suggested inhibitory role in gastri
c physiology.